Unlike with real-world coronaviruses (where we didn’t put much effort into studying or vaccinating them pre-2020, in spite of the dramatic warning bells that were SARS-1 and MERS), Sønheim and surrounding countries put a heck of a lot of research into brumaviruses.
We had to design a new vaccine from scratch. They just had to swap a few proteins in the template they’d already been finessing for decades.
Red: Huh . . . the vaccine’s out?
Yellow: Read it on my smartcrystal yourself!
Red: Wow . . . it’s only been two months, I thought it’d take longer . . .
Yellow: WELL, we already design new vaccines every year to stimulate an immune response to the predicted brumavirus strains, We just had to sequence the new virus and alter our previously-developed MRNA shots to generate its unique proteins, it only really took this long because of the time requirements for conducting basic phase-1 and 2 human safety trials.
Red: Wow! Where did you learn all that? Med school?
Yellow: Uh . . . I’ve been stuck in bed for weeks — I listened to a ton of medical podcasts.